Applied Nutrition（B52）株式概要アプライド・ニュートリション社は、英国内外でスポーツ栄養製品の製造、卸売、小売を行っている。 詳細B52 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長3/6過去の実績5/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より16.3%で取引されている 収益は年間11.42%増加すると予測されています 過去1年間で収益は80.4%増加しました リスク分析高いレベルの非現金収入 過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見るB52 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€3.2837.6% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0279m2016201920222025202620282031Revenue UK£278.7mEarnings UK£57.4mAdvancedSet Fair ValueView all narrativesApplied Nutrition Plc 競合他社BeiersdorfSymbol: XTRA:BEIMarket cap: €15.4bChongqing Baiya Sanitary ProductsSymbol: SZSE:003006Market cap: CN¥6.7bPharmanutraSymbol: BIT:PHNMarket cap: €877.1mBellRing BrandsSymbol: NYSE:BRBRMarket cap: US$1.0b価格と性能株価の高値、安値、推移の概要Applied Nutrition過去の株価現在の株価UK£3.2852週高値UK£3.3052週安値UK£1.43ベータ01ヶ月の変化40.17%3ヶ月変化29.13%1年変化120.13%3年間の変化n/a5年間の変化n/aIPOからの変化93.28%最新ニュースRecent Insider Transactions • Jun 07CFO & Director recently sold €1.8m worth of stockOn the 4th of June, Joseph Pollard sold around 550k shares on-market at roughly €3.19 per share. This transaction amounted to 46% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.Buy Or Sell Opportunity • Jun 04Now 21% undervaluedOver the last 90 days, the stock has risen 16% to €3.12. The fair value is estimated to be €3.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last year. Earnings per share has grown by 80%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €3.18, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in Europe. Total returns to shareholders of 109% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €3.85 per share.お知らせ • Jun 01Applied Nutrition plc Updates Earnings Guidance for Financial Year Ending 31 July 2026Applied Nutrition Plc updated earnings guidance for financial year ending 31 July 2026. The company an upgraded to its expectations for the period, and the Board now expects the Group's FY26 revenue to be ahead of current consensus market expectations at approximately £148 million. Consensus market expectations for FY26 as calculated by the Group immediately before this announcement are: Revenue of £140.3 million.Board Change • May 21High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Peter Cowgill was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Mar 23Applied Nutrition plc Provides Revenue Guidance for the Full Year 2026Applied Nutrition plc provided revenue guidance for the full year 2026. For the year, the Board anticipates full-year revenue of approximately £140 million.最新情報をもっと見るRecent updatesRecent Insider Transactions • Jun 07CFO & Director recently sold €1.8m worth of stockOn the 4th of June, Joseph Pollard sold around 550k shares on-market at roughly €3.19 per share. This transaction amounted to 46% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.Buy Or Sell Opportunity • Jun 04Now 21% undervaluedOver the last 90 days, the stock has risen 16% to €3.12. The fair value is estimated to be €3.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last year. Earnings per share has grown by 80%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €3.18, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in Europe. Total returns to shareholders of 109% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €3.85 per share.お知らせ • Jun 01Applied Nutrition plc Updates Earnings Guidance for Financial Year Ending 31 July 2026Applied Nutrition Plc updated earnings guidance for financial year ending 31 July 2026. The company an upgraded to its expectations for the period, and the Board now expects the Group's FY26 revenue to be ahead of current consensus market expectations at approximately £148 million. Consensus market expectations for FY26 as calculated by the Group immediately before this announcement are: Revenue of £140.3 million.Board Change • May 21High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Peter Cowgill was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Mar 23Applied Nutrition plc Provides Revenue Guidance for the Full Year 2026Applied Nutrition plc provided revenue guidance for the full year 2026. For the year, the Board anticipates full-year revenue of approximately £140 million.お知らせ • Feb 18Applied Nutrition plc Provides Revenue Guidance for the Fiscal Year 2026Applied Nutrition Plc provides revenue guidance for the fiscal year 2026. For the year, the company expects Reflecting the strong first-half performance, the Group now anticipates that FY26 results will be ahead of updated market consensus expectations. Management currently expects full-year revenue of approximately £140 million.お知らせ • Feb 17Applied Nutrition Plc to Report First Half, 2026 Results on Mar 23, 2026Applied Nutrition Plc announced that they will report first half, 2026 results on Mar 23, 2026お知らせ • Dec 11Applied Nutrition plc Provides Earnings Guidance for the Financial Year Ending July 31, 2026Applied Nutrition Plc provided earnings guidance for the financial year ending July 31, 2026. For the period, the Company now expects that results are likely to exceed current market consensus estimates by approximately 10%. Consensus market expectations for fiscal year 2026 before 9 December 2025 were revenue of £122.3 million.お知らせ • Nov 28Applied Nutrition Plc, Annual General Meeting, Jan 08, 2026Applied Nutrition Plc, Annual General Meeting, Jan 08, 2026. Location: the companys registered office, 2 acornfield road, knowsley industrial park, liverpool l33 7ug, United Kingdomお知らせ • Aug 19+ 1 more updateApplied Nutrition Plc to Report Fiscal Year 2025 Results on Nov 10, 2025Applied Nutrition Plc announced that they will report fiscal year 2025 results on Nov 10, 2025お知らせ • Aug 14AN Supps, A Division of Applied Nutrition PLC, Expands Innovation with Iconic Chiquita Brand Collab and A Nationwide Walmart U.S. LaunchAN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita earlier in 2025, with five co-branded sports nutrition products exclusively sold through The Vitamin Shoppe. The expanded partnership through Walmart allows shoppers to enjoy not only nutritious, healthy supplements so simple to use - but also a great-tasting source for beverage and food snacks, suited for many lifestyles. The AN ESSENTIAL line of Chiquita co-branded sports nutrition powders, exclusively from AN Supps, is now available at thousands of Walmart locations in the United States, and on Walmart.com. Walmart will be offering two protein powders from AN Supps, featuring the Chiquita co-branding - a banana chocolate whey protein, and a banana strawberry whey protein. Both are gluten-free, potassium enriched, and serves from each contain 20 grams of protein.AN Supps will further celebrate the bevy of fresh fruit that also define the Chiquita brand equity. Chiquita®? distributes fresh apples, berries, pineapples, grapes, melon and citrus worldwide. These inspire two additionalChiquita co- branded items at Walmarts nationwide: pineapple strawberry and fruit blend pre-workout powders. Much like the Chiquita fruits inspiring these powders, both are gluten-free, soy-free, vegan-friendly, and with no added sugar. The four AN Supps SKUs at Walmart U.S. locations, co-branded with Chiquita®?, include banana-ch chocolate whey protein; banana-strawberry whey protein; pineapple-strawberry pre-workout powder; and fruit blend pre-work out powder.お知らせ • Feb 14Applied Nutrition Plc to Report First Half, 2025 Results on Apr 08, 2025Applied Nutrition Plc announced that they will report first half, 2025 results on Apr 08, 2025株主還元B52DE Personal ProductsDE 市場7D3.1%4.0%-0.7%1Y120.1%-5.6%2.0%株主還元を見る業界別リターン: B52過去 1 年間で-5.6 % の収益を上げたGerman Personal Products業界を上回りました。リターン対市場: B52過去 1 年間で2 % の収益を上げたGerman市場を上回りました。価格変動Is B52's price volatile compared to industry and market?B52 volatilityB52 Average Weekly Movement5.8%Personal Products Industry Average Movement5.1%Market Average Movement6.0%10% most volatile stocks in DE Market13.1%10% least volatile stocks in DE Market2.8%安定した株価: B52 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: B52の 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2014270Tom Ryderappliednutrition.ukアプライド・ニュートリション社は、英国および海外でスポーツ栄養製品の製造、卸売、小売を行っている。ホエイプロテイン、ホエイプロテインアイソレート、カゼインプロテインパウダー、クリアプロテイン、ビーガンプロテイン、プロテインバー＆オーツ、プロテインシェイク＆缶、ビーフプロテイン、BCAAパウダー＆タブレット、BCAA缶、クレアチン、アミノ、エナジージェル＆ドリンク、プレワークアウトドリンク、パウダー、ジェル、水分補給＆ビタミンウォーター、水分補給タブレット、水分補給電解質＆ビタミンパウダー、エナジーショット、カフェインカプセル、マスゲイナーなどを提供。また、肝臓サポート、健康と活力、活力シリーズ、コラーゲン、ビタミン、調理用製品、ジムウェアやバッグ、ボトルやシェーカー、ファンネルやスクープ、デジタルウォッチなども提供している。アプライド・ニュートリション、ABEオールブラック・エブリシング、ボディフューエル、エンデュランスのブランドで製品を提供している。アプライド・ニュートリションは2014年に設立され、英国リバプールに本社を置いている。もっと見るApplied Nutrition Plc 基礎のまとめApplied Nutrition の収益と売上を時価総額と比較するとどうか。B52 基礎統計学時価総額€850.53m収益（TTM）€31.99m売上高(TTM)€155.33m26.6xPER（株価収益率5.5xP/SレシオB52 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計B52 損益計算書（TTM）収益UK£134.00m売上原価UK£72.20m売上総利益UK£61.80mその他の費用UK£34.20m収益UK£27.60m直近の収益報告Jan 31, 2026次回決算日該当なし一株当たり利益（EPS）0.11グロス・マージン46.12%純利益率20.60%有利子負債／自己資本比率0%B52 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/14 08:06終値2026/06/12 00:00収益2026/01/31年間収益2025/07/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Applied Nutrition Plc 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Adam TomlinsonBerenbergMark PhotiadesCanaccord GenuityAndrew Murray DarleyCavendish9 その他のアナリストを表示
Recent Insider Transactions • Jun 07CFO & Director recently sold €1.8m worth of stockOn the 4th of June, Joseph Pollard sold around 550k shares on-market at roughly €3.19 per share. This transaction amounted to 46% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.
Buy Or Sell Opportunity • Jun 04Now 21% undervaluedOver the last 90 days, the stock has risen 16% to €3.12. The fair value is estimated to be €3.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last year. Earnings per share has grown by 80%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €3.18, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in Europe. Total returns to shareholders of 109% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €3.85 per share.
お知らせ • Jun 01Applied Nutrition plc Updates Earnings Guidance for Financial Year Ending 31 July 2026Applied Nutrition Plc updated earnings guidance for financial year ending 31 July 2026. The company an upgraded to its expectations for the period, and the Board now expects the Group's FY26 revenue to be ahead of current consensus market expectations at approximately £148 million. Consensus market expectations for FY26 as calculated by the Group immediately before this announcement are: Revenue of £140.3 million.
Board Change • May 21High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Peter Cowgill was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 23Applied Nutrition plc Provides Revenue Guidance for the Full Year 2026Applied Nutrition plc provided revenue guidance for the full year 2026. For the year, the Board anticipates full-year revenue of approximately £140 million.
Recent Insider Transactions • Jun 07CFO & Director recently sold €1.8m worth of stockOn the 4th of June, Joseph Pollard sold around 550k shares on-market at roughly €3.19 per share. This transaction amounted to 46% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.
Buy Or Sell Opportunity • Jun 04Now 21% undervaluedOver the last 90 days, the stock has risen 16% to €3.12. The fair value is estimated to be €3.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last year. Earnings per share has grown by 80%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €3.18, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in Europe. Total returns to shareholders of 109% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €3.85 per share.
お知らせ • Jun 01Applied Nutrition plc Updates Earnings Guidance for Financial Year Ending 31 July 2026Applied Nutrition Plc updated earnings guidance for financial year ending 31 July 2026. The company an upgraded to its expectations for the period, and the Board now expects the Group's FY26 revenue to be ahead of current consensus market expectations at approximately £148 million. Consensus market expectations for FY26 as calculated by the Group immediately before this announcement are: Revenue of £140.3 million.
Board Change • May 21High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Peter Cowgill was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 23Applied Nutrition plc Provides Revenue Guidance for the Full Year 2026Applied Nutrition plc provided revenue guidance for the full year 2026. For the year, the Board anticipates full-year revenue of approximately £140 million.
お知らせ • Feb 18Applied Nutrition plc Provides Revenue Guidance for the Fiscal Year 2026Applied Nutrition Plc provides revenue guidance for the fiscal year 2026. For the year, the company expects Reflecting the strong first-half performance, the Group now anticipates that FY26 results will be ahead of updated market consensus expectations. Management currently expects full-year revenue of approximately £140 million.
お知らせ • Feb 17Applied Nutrition Plc to Report First Half, 2026 Results on Mar 23, 2026Applied Nutrition Plc announced that they will report first half, 2026 results on Mar 23, 2026
お知らせ • Dec 11Applied Nutrition plc Provides Earnings Guidance for the Financial Year Ending July 31, 2026Applied Nutrition Plc provided earnings guidance for the financial year ending July 31, 2026. For the period, the Company now expects that results are likely to exceed current market consensus estimates by approximately 10%. Consensus market expectations for fiscal year 2026 before 9 December 2025 were revenue of £122.3 million.
お知らせ • Nov 28Applied Nutrition Plc, Annual General Meeting, Jan 08, 2026Applied Nutrition Plc, Annual General Meeting, Jan 08, 2026. Location: the companys registered office, 2 acornfield road, knowsley industrial park, liverpool l33 7ug, United Kingdom
お知らせ • Aug 19+ 1 more updateApplied Nutrition Plc to Report Fiscal Year 2025 Results on Nov 10, 2025Applied Nutrition Plc announced that they will report fiscal year 2025 results on Nov 10, 2025
お知らせ • Aug 14AN Supps, A Division of Applied Nutrition PLC, Expands Innovation with Iconic Chiquita Brand Collab and A Nationwide Walmart U.S. LaunchAN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita earlier in 2025, with five co-branded sports nutrition products exclusively sold through The Vitamin Shoppe. The expanded partnership through Walmart allows shoppers to enjoy not only nutritious, healthy supplements so simple to use - but also a great-tasting source for beverage and food snacks, suited for many lifestyles. The AN ESSENTIAL line of Chiquita co-branded sports nutrition powders, exclusively from AN Supps, is now available at thousands of Walmart locations in the United States, and on Walmart.com. Walmart will be offering two protein powders from AN Supps, featuring the Chiquita co-branding - a banana chocolate whey protein, and a banana strawberry whey protein. Both are gluten-free, potassium enriched, and serves from each contain 20 grams of protein.AN Supps will further celebrate the bevy of fresh fruit that also define the Chiquita brand equity. Chiquita®? distributes fresh apples, berries, pineapples, grapes, melon and citrus worldwide. These inspire two additionalChiquita co- branded items at Walmarts nationwide: pineapple strawberry and fruit blend pre-workout powders. Much like the Chiquita fruits inspiring these powders, both are gluten-free, soy-free, vegan-friendly, and with no added sugar. The four AN Supps SKUs at Walmart U.S. locations, co-branded with Chiquita®?, include banana-ch chocolate whey protein; banana-strawberry whey protein; pineapple-strawberry pre-workout powder; and fruit blend pre-work out powder.
お知らせ • Feb 14Applied Nutrition Plc to Report First Half, 2025 Results on Apr 08, 2025Applied Nutrition Plc announced that they will report first half, 2025 results on Apr 08, 2025
